top of page
GSK IMMUNISATION AWARDS 2024
​

Submissions for the 2024 Awards closed on 6 March 2024. Applicants will be notified in late March.

GSK_Logo_Full_Colour_RGB.png

​The GSK Immunisation Awards have been developed to reward innovation that improves coverage and timely delivery of childhood, adolescent and adult immunisation. Four awards of AUD $20,000 each will be awarded to support initiatives that meet one or more of the following Award Criteria:

​

  • Improve access, coverage and/or timely delivery as per the Australian National Immunisation Program schedule;

  • Improve access, coverage and/or timely delivery for hard-to-reach populations (including geographically distant populations, new Australian immigrants, refugees, asylum seekers);

  • Utilise digital technology and/or social media to improve the Quality Use of Vaccines through innovation;

  • Improve access, coverage and/or timely delivery for indigenous populations;

  • Improve access, coverage and/or timely delivery for international travellers.

  • The programs submitted for award consideration should be adaptable by other immunisation groups.

​

In 2024 the GSK Immunisation Awards will be managed by the Public Health Association of Australia and Awards Winners will be announced at the Communicable Disease & Immunisation Conference Dinner on 12 June 2024.

​

Important Dates

 

  • Call for abstracts open - Thursday 25 January 2024

  • Call for abstracts close - Wednesday 6 March 2024, 11:59pm AEDT

  • Notification of abstract submission results - second half of March 2024

  • Finalist Applications open - Thursday 21 March 2024

  • Finalist Applications close - Wednesday 10 April 2024, 11:59pm AEST

  • Awards announced at the Communicable Diseases & Immunisation Conference Dinner - Wednesday 12 June 2024

​

Application Process

​

​Phase 1 – Call for Abstracts - (Phase 1)​​

Applicants are asked to submit an initial abstract outlining, in no more than 500 words, how the initiative being nominated for an Award meets one or more of the GSK Immunisation Award criteria.

​

Phase 2 – Finalists' Applications  

Finalists selected in Phase 1 will be invited to submit a Finalist Application, including:

  • a one-page executive summary;

  • an outline of the initiative’s activities, achievements to date and how the Award would support the initiative’s ongoing activities (maximum 2000 words);

  • at least one stakeholder testimonial.

​

Award Benefits

Award winners will receive:

  • AUD $20,000 awards prize, to be used to support the initiative's ongoing activities.

  • A GSK Immunisation Award trophy and certificate.

  • A travel award of up to AUD $3,000 to attend the 2025 Communicable Diseases & Immunisation Conference for the purpose of presenting on outcomes arising from the Award.

​

Reporting

Award winners will be required to submit a report on the initiative’s activities and outcomes arising from the Award. ​

​

Award Ceremony

Finalists will be invited to attend the 2024 CDIC Conference Dinner where the awards will be announced and will be provided with two complimentary tickets for the dinner per finalist application.

​
bottom of page